These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 16320498)
1. Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature. Pelletier R; Alarie I; Lagacé R; Walsh TJ Med Mycol; 2005 Sep; 43(6):559-64. PubMed ID: 16320498 [TBL] [Abstract][Full Text] [Related]
3. Caspofungin: a potential cause of reversible severe thrombocytopenia. Lynch J; Wong-Beringer A Pharmacotherapy; 2004 Oct; 24(10):1408-11. PubMed ID: 15628837 [TBL] [Abstract][Full Text] [Related]
4. Caspofungin: a review of its use in the treatment of fungal infections. McCormack PL; Perry CM Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025 [TBL] [Abstract][Full Text] [Related]
5. Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. Pemán J; Jarque I; Bosch M; Cantón E; Salavert M; de Llanos R; Molina A J Clin Microbiol; 2006 May; 44(5):1912-4. PubMed ID: 16672439 [TBL] [Abstract][Full Text] [Related]
6. Invasive candidiasis in cancer patients: observations from a randomized clinical trial. DiNubile MJ; Hille D; Sable CA; Kartsonis NA J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554 [TBL] [Abstract][Full Text] [Related]
7. A case of candida albicans mediastinitis after heart transplantation successfully treated with caspofungin. Garlicki M; Czub P; Filczak K; Wojdyga R; Puchniewicz M; Labuś K; Ehrlich MP Ann Transplant; 2006; 11(1):47-8. PubMed ID: 17025031 [TBL] [Abstract][Full Text] [Related]
9. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Kartsonis N; Killar J; Mixson L; Hoe CM; Sable C; Bartizal K; Motyl M Antimicrob Agents Chemother; 2005 Sep; 49(9):3616-23. PubMed ID: 16127030 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. López-Ciudad V; Castro-Orjales MJ; León C; Sanz-Rodríguez C; de la Torre-Fernández MJ; Pérez de Juan-Romero MA; Collell-Llach MD; Díaz-López MD BMC Infect Dis; 2006 Apr; 6():73. PubMed ID: 16608509 [TBL] [Abstract][Full Text] [Related]
11. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents. Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304 [TBL] [Abstract][Full Text] [Related]
12. Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. Kartsonis NA; Saah A; Lipka CJ; Taylor A; Sable CA J Antimicrob Chemother; 2004 May; 53(5):878-81. PubMed ID: 15044431 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150 [TBL] [Abstract][Full Text] [Related]
14. Comparison of caspofungin and amphotericin B for invasive candidiasis. Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J; N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683 [TBL] [Abstract][Full Text] [Related]
15. Caspofungin: a major breakthrough in treatment of systemic fungal infections. Agarwal MB; Rathi SA; Ratho N; Subramanian R J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin. Olver WJ; Scott F; Shankland GS Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561 [TBL] [Abstract][Full Text] [Related]
17. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol]. del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305 [TBL] [Abstract][Full Text] [Related]
18. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature. Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746 [TBL] [Abstract][Full Text] [Related]
19. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. Betts R; Glasmacher A; Maertens J; Maschmeyer G; Vazquez JA; Teppler H; Taylor A; Lupinacci R; Sable C; Kartsonis N Cancer; 2006 Jan; 106(2):466-73. PubMed ID: 16353208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]